Skip to main content

ADMA Biologics, Inc. (NASDAQ: ADMA) Investor Securities Class Action Lawsuit 06/10/2026

  • If you purchased a significant amount of shares of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9, 2024 and March 25, 2026, and / or if you purchased any NASDAQ: ADMA shares prior to August 2024 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: August 10, 2026. NASDAQ: ADMA investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

June 10, 2026 - An investor in shares of ADMA Biologics, Inc. (NASDAQ: ADMA) filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by ADMA Biologics, Inc. in connection with certain allegedly false and misleading statements made between August 9, 2024 and March 25, 2026.   Ramsey, NJ based ADMA Biologics, Inc., a b...



You must register (for free) or login to view the entire case.